OPK

1.10

0.00% 0.00

Dopo l'orario di chiusura: 1.12 0.02 +1.82%

Opko Health Inc (OPK)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché OPK Giù? Forum Previsione

Precedente Chiudi:

$1.10

Aprire:

$1.08

Volume 24 ore:

2.67M

Relative Volume:

1.14

Capitalizzazione di mercato:

$830.60M

Reddito:

$581.12M

Utile/perdita netta:

$-212.92M

Rapporto P/E:

-4.0175

EPS:

-0.2738

Flusso di cassa netto:

$-174.22M

1 W Prestazione:

-3.51%

1M Prestazione:

-6.78%

6M Prestazione:

-14.06%

1 anno Prestazione:

-17.29%

Intervallo 1D:

$1.075

$1.125

Intervallo di 1 settimana:

$1.075

$1.14

Portata 52W:

$0.9769

$1.60

Opko Health Inc Stock (OPK) Company Profile

Nome

Opko Health Inc

Settore

Healthcare (1101)

Industria

Diagnostics & Research (52)

Telefono

305-575-4181

Indirizzo

4400 BISCAYNE BLVD., MIAMI, FL

Dipendente

2,275

Cinguettio

Prossima data di guadagno

2026-04-28

Ultimi documenti SEC

OPK's Discussions on Twitter

Compare OPK vs TMO, DHR, IDXX, WAT, A

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
OPK Opko Health Inc	1.10	830.60M	581.12M	-212.92M	-174.22M	-0.2738
TMO Thermo Fisher Scientific Inc	438.34	166.56B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	161.91	116.46B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	528.79	42.03B	4.45B	1.10B	1.06B	13.59
WAT Waters Corp	329.22	32.72B	3.77B	449.25M	240.68M	7.8556
A Agilent Technologies Inc	111.70	32.01B	7.07B	1.29B	993.00M	4.5355

Opko Health Inc Stock (OPK) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-11-20	Iniziato	JP Morgan	Neutral
2025-10-31	Downgrade	Jefferies	Buy → Hold
2025-04-25	Iniziato	JP Morgan	Neutral
2023-06-29	Aggiornamento	Barrington Research	Mkt Perform → Outperform
2022-12-15	Iniziato	H.C. Wainwright	Buy
2022-01-24	Downgrade	Barrington Research	Outperform → Mkt Perform
2021-06-21	Iniziato	Ladenburg Thalmann	Buy
2019-11-25	Iniziato	Piper Jaffray	Overweight
2018-03-02	Downgrade	JP Morgan	Neutral → Underweight
2017-09-14	Downgrade	JP Morgan	Overweight → Neutral
2016-06-21	Reiterato	Standpoint Research	Buy
2016-06-03	Iniziato	Standpoint Research	Buy
2016-03-31	Reiterato	Barrington Research	Outperform
2015-10-16	Iniziato	JP Morgan	Overweight
2015-09-11	Downgrade	Jefferies	Buy → Hold
2015-03-03	Downgrade	Oppenheimer	Outperform → Perform
2014-05-12	Reiterato	Oppenheimer	Outperform
2014-03-14	Iniziato	Oppenheimer	Outperform
2013-11-13	Reiterato	Ladenburg Thalmann	Buy
2013-05-30	Reiterato	Ladenburg Thalmann	Buy
2012-10-22	Iniziato	Barrington Research	Outperform
2011-12-01	Reiterato	Ladenburg Thalmann	Buy
2011-07-14	Iniziato	Ladenburg Thalmann	Buy

Mostra tutto

Opko Health Inc Borsa (OPK) Ultime notizie

May 14, 2026

OPKO Health stock (US68375N1037): Genomics leader with recent subsidiary activity - AD HOC NEWS

May 14, 2026

OPKO Health (OPK) price target increased by 11.18% to 3.86 - MSN

May 14, 2026

May 12, 2026

ModeX to present preclinical CAR-T data at gene therapy meeting - Investing.com UK

May 12, 2026

OPKO Health’s ModeX Therapeutics Will Present Data Demonstrating In Vivo CAR-T Cell Generation and Deep B-Cell Depletion in Preclinical Studies - Yahoo Finance

May 12, 2026

May 11, 2026

OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

May 06, 2026

May 05, 2026

MSN Money - MSN

May 05, 2026

OPK Stock Price, Quote & Chart | OPKO HEALTH INC (NASDAQ:OPK) - ChartMill

May 05, 2026

May 03, 2026

OPKO Health, Inc. (NASDAQ:OPK) Just Reported And Analysts Have Been Lifting Their Price Targets - 富途牛牛

May 03, 2026

May 01, 2026

HC Wainwright Boosts Earnings Estimates for OPKO Health - MarketBeat

May 01, 2026

OPKO Health : Notice Annual Meeting of stockholders be held on Thursday, June 18, 2026. - marketscreener.com

May 01, 2026

Apr 30, 2026

OPKO gains 15% stake in Nicoya for China RAYALDEE rights - Investing.com UK

Apr 30, 2026

[ARS] OPKO HEALTH, INC. SEC Filing - Stock Titan

Apr 30, 2026

Board structure and pay detailed in OPKO Health (NASDAQ: OPK) 2026 proxy - Stock Titan

Apr 30, 2026

OPKO gains 15% stake in Nicoya for China RAYALDEE rights By Investing.com - Investing.com South Africa

Apr 30, 2026

OPKO Health receives 15% stake in Nicoya for China drug rights - StreetInsider

Apr 30, 2026

OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China - marketscreener.com

Apr 30, 2026

Q1 Earnings Estimate for OPKO Health Issued By HC Wainwright - MarketBeat

Apr 30, 2026

Order lab tests online or at home: BioReference opens new platform - Stock Titan

Apr 30, 2026

Apr 29, 2026

OPKO Health (OPK) reports Q1 loss, misses revenue estimates - MSN

Apr 29, 2026

OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/Y - sharewise.com

Apr 29, 2026

OPKO Health Down Over 13%, On Pace for Largest Percent Decrease Since January 2024 -- Data Talk - Moomoo

Apr 29, 2026

OPKO Health (NASDAQ:OPK) Hits New 1-Year LowShould You Sell? - MarketBeat

Apr 29, 2026

This Purple Innovation Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga

Apr 29, 2026

H.C. Wainwright reiterates Opko Health stock rating on Q1 results By Investing.com - Investing.com Australia

Apr 29, 2026

OPKO Health (NASDAQ:OPK) Downgraded to "Market Perform" Rating by Barrington Research - MarketBeat

Apr 29, 2026

H.C. Wainwright reiterates Opko Health stock rating on Q1 results - Investing.com

Apr 29, 2026

OPKO Health Q1 2026 Earnings Call: Complete Transcript - Benzinga

Apr 29, 2026